Stefanos Zenios is Professor at Stanford Graduate School of Business with dual appointments in Entrepreneurship and Operations, Information & Technology . He directs Stanford GSB’s Center for Entrepreneurial Studies and co-directs the Doerr School of Sustainability ’s Program in Ecopreneurship. His Startup Garage course has launched companies like DoorDash while alumni have raised over $3B in venture capital. He co-authored the foundational Biodesign textbook and previously served as Editor-in-Chief of Operations Research . PhD, MIT Operations Research (1996) MA, University of Cambridge (1996) BA, University of Cambridge (1992) Research Focus Dr. Zenios’ work bridges operations research and innovation management , with significant contributions to: Healthcare operations : Administrative cost reduction, organ allocation optimization, and clinical workflow improvements Entrepreneurship : Venture creation frameworks and experiential education Ecopreneurship : Sustainable business model innovation His Precedents Thinking framework (HBR 2025) has gained global recognition for solving systemic inefficiencies. Current research includes the biennial Search Fund Study with Peter Kelly. Scientific Recognition INFORMS Fellow Multiple Best Paper Awards, INFORMS CAREER Award, National Science Foundation (2000) Dhirubhai Ambani Faculty Fellow (2017–2020) George E. Nicholson Award (1997) He has received extensive media coverage in Fast Company , Time Magazine , and Stanford Business . His research has been featured in over 150 press mentions including JAMA , Harvard Business Review , and Health Affairs .
Charles E. Leonard is an Associate Professor of Epidemiology at the Perelman School of Medicine , University of Pennsylvania. He holds affiliations with multiple Penn-based institutions, including the Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Institute for Translational Medicine and Therapeutics, Leonard Davis Institute, Institute on Aging, and Center of Excellence in Environmental Toxicology. Additionally, he serves as a Special Government Employee at the FDA and Honorary Lecturer at Muhimbili University of Health and Allied Sciences in Tanzania. Pharmacoepidemiology Post-market prescription drug safety Causal inference methods Real-world evidence generation Environmental health impacts on chronic disease Dr. Leonard’s research focuses on generating real-world evidence to address critical gaps in drug safety, particularly for: Population health effects of drug interactions Comparative safety of antidiabetes drugs Drug-induced sudden cardiac arrest Ambient temperature extremes and chronic disease Pharmacoepidemiology methods development His work is primarily funded by the National Institutes of Health (NIH) and has been recognized through multiple awards, including the 2024 Harold I. Feldman Distinguished Scholar Award and the 2020 Elected Fellow status at the International Society for Pharmacoepidemiology. He also contributes to curriculum development and student mentoring in Penn’s Graduate Group in Epidemiology and Biostatistics. 2024 – Harold I. Feldman Distinguished Scholar Award (Penn) 2024 – Ronald D. Mann Best Paper Award (ISPE) 2020 – Leadership Medallion (BPS) 2019 – Abraham G. Hartzema Distinguished Lecturer (University of Florida)
Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .
Vishal Ahuja is an Associate Professor and Corrigan Research Professor at Southern Methodist University's Cox School of Business, with adjunct faculty status at University of Texas Southwestern Medical Center. He focuses on decision analytic tools for healthcare improvement through operations management. PhD, University of Chicago Booth School of Business MBA, University of Chicago Booth School of Business His research interests span healthcare operations, service optimization, and AI applications in clinical decision-making. He collaborates with the Department of Veterans Affairs, Parkland Hospital, and pediatric institutions to address care quality and delivery efficiency. Recent publications emphasize predictive modeling for chronic disease management, adaptive clinical trial design, and regulatory healthcare policy. Awards include the Dlin/Fischer Clinical Research Award (2021), INFORMS Pierskalla Award (2012), and 2025 AI75 recognition for Dallas-Fort Worth AI leadership. D CEO Excellence in Healthcare Award - Outstanding Healthcare Innovator (2023) NSF Game Changer Academies for Advancing Research Innovation (2022) C. Jackson Grayson Faculty Innovation Award (2022-23) At SMU, he teaches graduate courses in operations, supply chain, and service management, integrating corporate sector experience from chemical and consumer goods industries. His work has been cited by the FDA in safety labeling changes workshops.
Bruce H. Alexander, PhD, serves as Professor and Division Head of Environmental Health Sciences at the University of Minnesota's School of Public Health. His educational background includes a PhD in Epidemiology from the University of Washington (1994), an MS in Environmental Health from Colorado State University (1987), and a BS in the same field from Colorado State University (1984). Dr. Alexander is an occupational and environmental epidemiologist whose research spans environmental determinants of cancer and respiratory disease, injury prevention and control, One Health approaches, agricultural population health, and global health initiatives. His work emphasizes multidisciplinary approaches to address complex public health problems and building public health research and practice capacity. His expertise encompasses occupational and environmental epidemiology, environmental exposures, infectious disease, injuries, occupational health, One Health frameworks, global health, and agricultural health. Analysis of his recent publications (2019-2024) reveals a continued focus on occupational exposures, environmental health risks, and injury epidemiology across diverse populations and settings. His research demonstrates methodological diversity including cohort studies, systematic reviews, and meta-analyses addressing chemical exposures, UV radiation risks, temperature-related injuries, and mineral particle exposures in mining contexts. Scientific Recognition Member, Delta Omega Honorary Society in Public Health Mayo Professor of Public Health, School of Public Health, University of Minnesota (2016) Faculty Excellence Award, Division of Environmental and Occupational Health, University of Minnesota (2002) Dr. Alexander maintains active professional affiliations with major epidemiological organizations including the Society for Epidemiologic Research, International Society for Environmental Epidemiology, American College of Epidemiology, International Commission on Occupational Health, and Delta Omega. His work through the Upper Midwest Agricultural Safety and Health Center (UMASH) and Midwest Center for Occupational Health and Safety demonstrates commitment to translating research into practice for worker safety and health.
University of California, San FranciscoUnited States
Iona Cheng is a Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF), where she conducts groundbreaking research in cancer epidemiology. She serves as co-Investigator of the SEER Greater Bay Area Cancer Registry and is Principal Investigator of multiple NIH- and foundation-funded projects examining genetics, lifestyle factors, and neighborhood characteristics in relation to cancer risk. Dr. Cheng has developed an extensive research program focused on racial/ethnic differences in cancer risk and leads population-based cancer surveillance studies that document variations in cancer incidence and mortality patterns across diverse racial and ethnic groups. University of California, Davis, BS, 1990–1994, Physiology Yale University, MPH, 1999–2001, Chronic Disease Epidemiology University of Southern California, PhD, 2001–2005, Epidemiology University of California, San Francisco, Postdoc, 2006–2008, Genetic and Molecular Epidemiology Dr. Cheng's research spans multiple disciplines within cancer epidemiology, with particular emphasis on understanding how environmental exposures, genetic factors, and social determinants interact to influence cancer risk and outcomes across different racial and ethnic populations. Her work frequently examines the impact of air pollution, endocrine-disrupting chemicals, and neighborhood characteristics on cancer development and survival. She has made significant contributions to understanding cancer disparities among Asian American, Native Hawaiian, and Pacific Islander populations, bringing attention to the unique cancer risks and outcomes within these understudied groups. Her research often leverages the Multiethnic Cohort Study, one of the largest prospective studies of cancer incidence and mortality across diverse racial/ethnic populations. Analysis of Dr. Cheng's recent publications reveals a consistent focus on environmental and social determinants of cancer risk across multiple organ sites. Her work demonstrates a sophisticated integration of epidemiological methods with environmental exposure assessment, genetic analysis, and health disparities research. Many of her studies examine the intersection of environmental exposures and racial/ethnic disparities in cancer outcomes, particularly regarding breast cancer, lung cancer, and other malignancies. She has published extensively on the impact of air pollution on cancer risk and survival, as well as the effects of endocrine-disrupting chemicals like bisphenol A, parabens, and phthalates. American Association for Cancer Research Scholar-in-Training Award (2007) National Institutes of Health Loan Repayment Award (2007) National Institutes of Health Loan Repayment Renewal Award (2009) American Association for Cancer Research Faculty Scholar Award (2011) National Institutes of Health Loan Repayment Renewal Award (2011) National Institutes of Health Loan Repayment Renewal Award (2013) American Journal of Epidemiology/Society of Epidemiology Research Top 10 manuscripts (2014) Cancer Prevention Institute of California Mentoring Award (2015) American Society of Human Genetics Top poster As Principal Investigator of multiple NIH-funded projects, Dr. Cheng oversees substantial research grants focused on cancer epidemiology and health disparities. Her work often involves large interdisciplinary collaborations with researchers across multiple institutions, including the Multiethnic Cohort Study which follows over 200,000 participants from diverse racial/ethnic backgrounds. She has demonstrated leadership in mentoring junior researchers, particularly those from underrepresented backgrounds in science, as evidenced by her Cancer Prevention Institute of California Mentoring Award. Her research program integrates data from cancer registries, electronic health records, and geospatial information to provide comprehensive insights into cancer patterns and risk factors. Dr. Cheng's research is closely connected to the UCSF Helen Diller Family Comprehensive Cancer Center and leverages collaborations with Lawrence Berkeley National Laboratory, which provides advanced technological resources for cancer research. Her work benefits from access to extensive cohort data, sophisticated exposure assessment methods, and interdisciplinary expertise in genetics, environmental science, and computational biology available through these institutional partnerships. She frequently collaborates with researchers studying the genetic and environmental determinants of cancer across multiple organ systems, contributing to a more comprehensive understanding of cancer etiology and prevention strategies.
Lee H. Schwamm, MD is Associate Dean for Digital Strategy and Transformation at Yale School of Medicine and Senior Vice President & Chief Digital Health Officer for Yale New Haven Health System. He holds professorships in both Biomedical Informatics & Data Sciences and Neurology at Yale School of Medicine. Previously, he spent three decades at Mass General Brigham Health System where he served as Executive Vice Chair of Neurology, Director of the Center for TeleHealth at Massachusetts General Hospital, and Vice President for Digital Patient Experience and Virtual Care. Dr. Schwamm is an internationally recognized expert in stroke diagnosis, treatment and prevention, with particular expertise in telestroke and digital health applications in neurology. His research focuses on stroke in young patients, cryptogenic strokes, patterns of stroke care delivery, and addressing health inequities in stroke outcomes. He has been a pioneer in telehealth, especially in telestroke services, and has served as a policy advisor for the American Heart Association. His work has resulted in over 500 peer-reviewed publications with recent research emphasizing digital health solutions, AI applications in stroke care, social determinants of health impacts on stroke outcomes, and quality improvement in stroke care delivery. Under his leadership, the AHA Get with the Guidelines–Stroke Registry has grown into the world's largest stroke registry with over 8 million patient encounters. Fellow of the American Heart Association Fellow of the American Academy of Neurology Fellow of the American Neurological Association Digital health section editor for Stroke journal Member of Lancet Digital Health international advisory board Dr. Schwamm led the adoption of virtual care for 10,000 clinicians during the first six months of the COVID-19 pandemic, facilitating over 1.7 million virtual visits. He champions redesigning care delivery through a human-centered lens, leveraging technology to improve patient outcomes while reducing healthcare disparities. His educational background includes an AB in Philosophy from Harvard University (1985) and an MD from Harvard Medical School (1991), followed by neurology residency and stroke fellowship at Massachusetts General Hospital.
Dr. Kanwaljeet S. Anand is a dual-appointed Professor of Pediatrics (Pediatric Critical Care) and Anesthesiology, Perioperative & Pain Medicine at Stanford University School of Medicine. As director of the Pain/Stress Neurobiology Lab and Jackson Vaughan Critical Care Research Fund, he serves as Editor-in-Chief of Pediatric Research and maintains active membership in Bio-X, MCHRI, and Wu Tsai Neurosciences Institute. Rhodes Scholar with D.Phil from University of Oxford Harvard postdoctoral fellowship and Boston Children's Hospital residency Founded Harmony Health Clinic - Arkansas' largest charitable medical-dental facility A translational researcher with 30+ years of impact, Dr. Anand established the first scientific framework for infant pain perception and developed novel pain assessment methodologies. Current research focuses on: Hair biomarker analysis for stress and social affiliation (cortisol/oxytocin) Machine learning systems for objective pain detection in non-verbal infants Biopsychosocial interventions for stress reduction in disadvantaged youth Neurotoxicity mechanisms of sedatives in developing brains Global NICU opioid usage patterns through the NeoOpioid Consortium His work has yielded over 260 publications and significant advances in: Pediatric pain management protocols Neonatal stress biomarker development Critical care neurobiology insights Community health initiatives AI-driven clinical decision support systems Scientific Recognition 9th Annual 'In Praise of Medicine' Public Address, Erasmus University (2014) Nightingale Excellence Award (2016) Honorary Doctorate from University of Örebro (2019) NIH SBIB-H82 Study Section Chair (2018) Multiple IASP and American Pain Society awards Swedish Academy of Medicine's Nils Rosén von Rosenstein Award (2009) St. Jude Endowed Chairholder (2010) As mentor to Med Scholar Anjali Gupta and advisor to numerous professional bodies, Dr. Anand maintains active clinical leadership in Pediatric Intensive Care while advancing computational approaches to pain detection through collaborations with Stanford's AI researchers.
Jenny S. Guadamuz is an Assistant Professor of Health Policy and Management at the University of California, Berkeley School of Public Health. She serves as Director of the Health Equity Research Program at the Center for Health Management and Policy Research and is a member of the Latinx and Democracy Faculty Cluster. Her interdisciplinary research focuses on structural determinants affecting healthcare access for minoritized populations, particularly examining immigration status as a driver of health inequities. Postdoctoral Fellow – University of Southern California PhD – University of Illinois Chicago MS – University of Illinois Chicago BA – Saint Louis University Dr. Guadamuz's research spans drug utilization disparities, federal policy impacts on medication access, and geospatial analysis of pharmacy closures. Her recent work includes studies on prescription medication barriers among immigrants, cancer treatment disparities linked to socioeconomic status, and the effects of Medicare Part D policies on pharmacy access. She employs mixed-methods approaches using electronic health records, administrative claims, and social media data. Scientific Recognition: Robert Wood Johnson Foundation Health Policy Research Scholar National Heart, Lung, and Blood Institute T32 Fellow
Afsan Bhadelia, PhD, MS is an Assistant Professor in the Department of Public Health at Purdue University, where she teaches PUBH 240 – Global Health . Her nearly two decades of global-health scholarship focus on health-systems analysis, equity-oriented priority-setting, and the integration of palliative care for chronic diseases, notably cancer. Education: PhD – Johns Hopkins University MS – Tufts University BS – Tufts University Research Interests: Dr. Bhadelia’s transdisciplinary programme sits at the intersection of public health, complexity science, ethics, economics, and policy . She develops novel methodologies and metrics to illuminate social and structural determinants of health—using cancer and palliative care as tracer conditions—and embeds a gender-justice lens throughout. Her overarching goal is citizen-driven priority-setting that aligns health-system investments with societal values. Awards & Recognition: Fulbright U.S. Scholar (2021) Gordis Teaching Fellowship, Johns Hopkins Bloomberg School of Public Health (2015) Young Cancer Leader, Union for International Cancer Control (2015) Presidential Award for Citizenship and Public Service, Tufts University (2006) Research Trajectory & Impact: Bhadelia’s prolific publication record (46+ papers) charts a clear arc from quantifying the global burden of serious health-related suffering to crafting ethically-grounded, policy-ready solutions. Recurring themes include opioid-access equity, racism and casteism in pain relief, and integration of palliative care into universal health coverage. Her 2025 updates to the Lancet Commission, alongside multiple WHO-aligned metrics papers, position her work at the forefront of global palliative-care science. Community-Engaged Scholarship & Teaching: Emphasising community-partnered research, she mentors students in community-engaged methods and co-develops curricula that blend complexity thinking with real-world policy challenges. Through Purdue’s signature research areas— Developmental Health & Wellness, Healthy Lifestyles & Vital Longevity, Sustainable Organizations & Thriving Communities —her lab collaborates across disciplines to ensure research uptake by policymakers and practitioners.
Lauren Zalla, PhD, MS, is a Research Associate at the Bloomberg School of Public Health and School of Medicine at Johns Hopkins University. She holds a PhD in Epidemiology from UNC Chapel Hill (2022) and an MS in Public Health from Duke University (2015). Her work focuses on policy approaches to improve health outcomes and reduce inequities among people with HIV in the United States. PhD, University of North Carolina at Chapel Hill (2022) MS, Duke University (2015) Dr. Zalla examines social and structural determinants of health, racial disparities, and effectiveness of interventions like the Ending the HIV Epidemic Initiative and state AIDS Drug Assistance Programs. Her methodological contributions include improving disparity measurement, causal inference techniques, and sub-population estimation. Recent publications analyze spatio-temporal mortality patterns, antidepressant impacts on viral suppression, and integrase inhibitor associations with diabetes in HIV populations. Key awards include the 2025 Lilienfeld Postdoctoral Paper Prize Finalist and 2023 Delta Omega Honorary Society membership. 2025 Lilienfeld Postdoctoral Paper Prize Finalist 2023 Health Disparities Scholar 2023 Bernard G. Greenberg Award 2022 Tyroler Student Paper Prize Finalist Her research integrates spatial epidemiology, causal modeling, and policy evaluation to address systemic inequities in HIV care. Collaborations span clinical and population health domains with major journals including JAMA, American Journal of Epidemiology, and AIDS.
University of California, San FranciscoUnited States
Conan MacDougall, PharmD, MAS, BCPS, BCIDP, FIDSA serves as Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the University of California, San Francisco (UCSF) School of Pharmacy. He provides clinical service to the Infectious Diseases Consult Service at UCSF Medical Center and is actively involved in teaching pharmacy, medical, and nursing trainees at UCSF. Dr. MacDougall holds leadership positions including Chair of the Specialty Council on Infectious Diseases for the Board of Pharmaceutical Specialties and is a member of the School of Medicine's Academy of Medical Educators. Dr. MacDougall's educational background includes: MAS in Clinical Research from University of California, San Francisco (2008) PharmD from University of California, San Francisco (2002) BS in Chemistry from University of California, Davis (1998) Dr. MacDougall's research focuses on innovative approaches to antimicrobial stewardship, interactive learning methods for appropriate antimicrobial use, and the pharmacoepidemiology of antimicrobial utilization in hospitals. His work bridges clinical practice with educational innovation, particularly in developing effective instructional strategies for infectious diseases education. He has made significant contributions to understanding antibiotic resistance patterns, drug-drug interactions involving rifamycins, and the implementation of antimicrobial stewardship programs across healthcare settings. Analysis of Dr. MacDougall's most recent publications reveals a consistent focus on antimicrobial stewardship, infectious diseases education, and pharmacy practice. His research spans clinical investigations of antibiotic efficacy, educational interventions for healthcare professionals, and systematic reviews of drug interactions. Notably, his 2025 publications include important work on the role of infectious diseases pharmacists in antimicrobial stewardship and explorations of how artificial intelligence can support clinical decision-making in infectious diseases pharmacotherapy. Dr. MacDougall has received numerous prestigious awards recognizing his contributions to pharmacy and medical education: Fellow, Infectious Diseases Society of America (2025) Academic Senate Award for Distinction in Teaching, UCSF (2024) Vincent Pons Award for Clinical Infectious Diseases Education, UCSF School of Medicine (2019) Emerging Teaching Scholar Award, American Association of Colleges of Pharmacy (2018) Albert B. Prescott Pharmacy Leadership Award (2012) Multiple Long Prizes for Excellence in Teaching from UCSF School of Pharmacy (2006-2018) As an educator, Dr. MacDougall has twice received the Academic Senate Campus Award for Distinction in Teaching and has been recognized as an Emerging Teaching Scholar by the American Association of Colleges of Pharmacy. He serves as Antimicrobial Section Editor for Goodman & Gilman's The Pharmacological Basis of Therapeutics and is a chapter author in several major medical references including Principles and Practice of Infectious Diseases. His research has been consistently funded through various grants supporting investigations into antimicrobial utilization, educational interventions, and clinical outcomes related to infectious diseases management. Dr. MacDougall has supervised numerous pharmacy students and residents, contributing significantly to the training of future pharmacists specializing in infectious diseases. Dr. MacDougall is actively involved with the UCSF Infectious Diseases Management Program and collaborates with interdisciplinary teams across UCSF Medical Center. His work with the Infectious Diseases Society of America extends to curriculum development initiatives, including the Core Antimicrobial Stewardship Curriculum for Infectious Diseases Fellows. He also contributes to national efforts through his role on the Specialty Council on Infectious Diseases for the Board of Pharmaceutical Specialties, helping to shape certification standards for infectious diseases pharmacotherapy specialists.
Nathorn Chaiyakunapruk is a Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy . He holds an adjunct appointment in Population Health Sciences and serves on multiple institutional committees including the Global Health Steering Committee and Health Economics Core at CTSI . His academic leadership extends to international roles with the World Health Organization and founding initiatives like the ISPOR Asia Consortium . Education : PhD in Pharmaceutical Outcomes Research, University of Washington PharmD, University of Wisconsin-Madison BS in Pharmaceutical Science, Chulalongkorn University Research Interests span health technology assessment , global health economics , and evidence synthesis . His work applies methodologies like network meta-analysis and umbrella reviews to address health equity, infectious disease modeling, and pharmaceutical policy. Recent studies focus on social determinants of health and vaccine economic value . Article Trends highlight collaborations in AI-assisted systematic reviews , vaccine rollout optimization , and health disparities . His publications frequently address cost-effectiveness and global health burden across infectious and non-communicable diseases. Scientific Awards : Senior Class (P4) Distinguished Teacher (2022) NRCT Outstanding Research Award (2019, 2012) Monash University PVC Research Award (2015) Nagai Research Foundation Awards (2006-2010) ISPOR Task Force Leadership (CHEERS 2022) Teaching & Service : Courses include Systematic Review and Meta-analysis and Global Health Policy . He chairs the Asia Pacific Evidence-based Medicine Network and advises WHO on vaccine economics and Thailand’s National Health Security Office on pharmaceutical policy.
Memorial Sloan Kettering Cancer CenterUnited States
James Flory, MD, is a physician scientist at Memorial Sloan Kettering Cancer Center, where he specializes in endocrinology with a focus on diabetes management in cancer patients. He holds an MD from the University of Pennsylvania and completed residencies and fellowships at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Memorial Sloan Kettering. His research explores the safety and effectiveness of diabetes medications, particularly in oncology contexts. His work includes clinical studies on metformin's role in diabetes care, methodological tutorials on instrumental variable analysis in pharmacoepidemiology, and investigations into sulfonylureas' cardiovascular effects. Recent studies examine environmental factors like temperature impacts on antidiabetes drug outcomes. While not explicitly stated, his collaborations with oncologists like Serena Wong highlight his commitment to integrated care for patients with cancer-related metabolic complications.
Dustin D. French, PhD, serves as Professor in Ophthalmology and Medical Social Sciences (Determinants of Health) at Northwestern University's Feinberg School of Medicine. His dual appointments bridge clinical ophthalmology with population health research, focusing on healthcare system optimization through economic and policy analyses. Dr. French's educational foundation includes: PhD from The Ohio State University (2001) His research program centers on health economics and outcomes research , with signature expertise in: Comparative and cost-effectiveness methodologies Health informatics and big data applications Health services research and policy evaluation Addressing health disparities in diabetic eye care and rural communities Recent publications reveal a strategic focus on AI-driven clinical decision support and resource optimization, with 2025 studies examining glaucoma identification algorithms, nursing home quality metrics, microhematuria diagnostic pathways, and pediatric obesity interventions. Dr. French's scholarly impact is recognized through prestigious awards: International Society for Pharmacoepidemiology Outstanding Reviewer Award (2016, 2010) Department of Veterans Affairs Distinguished Service Award (2016) International Society for Pharmacoepidemiology Distinguished Article Award (2006) His leadership in health services research extends to mentorship and grant-funded initiatives targeting healthcare quality improvement, particularly in diabetic eye care access for minority populations. Institutional affiliations include the Center for Diabetes and Metabolism, IPHAM's Center for Health Services & Outcomes Research, and NUCATS, where he contributes to translational research infrastructure.
